{"id":"W2003492008","doi":"10.1158/0008-5472.sabcs12-s6-5","title":"Abstract S6-5: Primary results of BEATRICE, a randomized phase III trial evaluating adjuvant bevacizumab-containing therapy in triple-negative breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Taxane; Internal medicine; Breast cancer; Oncology; Bevacizumab; Anthracycline; Triple-negative breast cancer; Randomized controlled trial; Cancer; Mastectomy; Adjuvant; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003187667,0.001708895,0.00210452,0.0003553315,0.0004072154,0.001048626,0.001044782,0.001881025,0.007649029],"category_scores_gemma":[0.002557587,0.0004460517,0.001601509,0.0003134604,0.0009206688,0.0007305096,0.0004529868,0.003075519,0.001240493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008143585,"about_ca_system_score_gemma":0.001202549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001167348,"about_ca_topic_score_gemma":0.003056587,"domain_scores_codex":[0.9989832,0.0006641053,0.00004403222,0.0001262717,0.00008178491,0.0001004775],"domain_scores_gemma":[0.9983631,0.0003990292,0.0003141628,0.0001076347,0.0001042329,0.0007118228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9691908,0.008898977,0.0007864985,0.0004923886,0.001079348,0.00004726197,0.00004311673,0.0003928469,0.003192743,0.0001140391,0.002374938,0.01338711],"study_design_scores_gemma":[0.92493,0.07044583,0.002053243,0.00003110134,0.0006140668,0.00004170548,0.00001027522,0.0003104751,0.0004401664,0.0001030849,0.001008616,0.00001144759],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733179,0.006118407,0.0007473661,0.001712966,0.0004325458,0.006311293,0.00391952,0.000143959,0.007296086],"genre_scores_gemma":[0.9723147,0.002700821,0.002537169,0.002908649,0.0006237673,0.005138645,0.006625871,0.00004189209,0.007108485],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007649029,"threshold_uncertainty_score":0.02558857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08876426467014656,"score_gpt":0.4489294832525908,"score_spread":0.3601652185824442,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}